ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103 | -1.0% | 34,497 | +10.6% | 0.00% | 0.0% |
| Q1 2023 | $104 | -44.7% | 31,179 | -20.1% | 0.00% | -50.0% |
| Q4 2022 | $188 | -100.0% | 39,042 | -50.5% | 0.00% | -66.7% |
| Q3 2022 | $449,000 | -3.2% | 78,839 | +20.7% | 0.01% | +20.0% |
| Q2 2022 | $464,000 | +199.4% | 65,320 | +276.2% | 0.01% | +400.0% |
| Q4 2021 | $155,000 | -88.3% | 17,361 | -53.9% | 0.00% | -83.3% |
| Q3 2021 | $1,321,000 | +908.4% | 37,684 | +1678.4% | 0.01% | +500.0% |
| Q1 2021 | $131,000 | – | 2,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |